Cart summary

You have no items in your shopping cart.

Topotecan hydrochloride

SKU: orb1309516

Description

Topotecan hydrochloride (NSC 609699) is a small molecule topoisomerase I inhibitor used as an antineoplastic agent. It is applied in ovarian cancer research and has been extensively studied in both in vitro cytotoxicity assays and in vivo xenograft models.

Research Area

Cell Biology, Molecular Biology

Images & Validation

Key Properties

CAS Number119413-54-6
MW457.92
Purity99.41% (May vary between batches)
FormulaC23H24ClN3O5
SMILESCl.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O
TargetAutophagy,Topoisomerase,Apoptosis
SolubilityH2O:45.8 mg/mL (100.02 mM);DMSO:100 mg/mL (218.38 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (8.74 mM)

Bioactivity

Target IC50
Topo I (DU-145 Luc cells):2 nM|Topo I (MCF-7 Luc cells):13 nM
In Vivo
In radiation-resistant human B-lineage acute lymphoblastic leukemia cells, Topotecan stabilizes topoisomerase I/DNA cleavable complexes, inducing rapid apoptosis regardless of high bcl-2 protein expression, and inhibits clonal growth of the cells in a dose-dependent manner. Topotecan exhibits augmented drug activity against DU-145 Luc and MCF-7 Luc cells. During DNA replication, its cytotoxic action is mediated by stabilizing the covalent complex between topoisomerase I and DNA, preventing religation of the enzyme-linked single-strand DNA breaks.
In Vitro
Topotecan induces effective anti-leukemic activity in a severe combined immunodeficient (SCID) mouse model of poor-prognosis acute lymphoblastic leukemia (ALL). Its administration significantly prolongs the disease-free survival in SCID mice challenged with a lethal dose of human leukemia cells at systemic drug exposure levels. Glioblastomas preferentially express TNF-related apoptosis-inducing ligand receptor 2 (TRAIL R2), and Topotecan treatment notably upregulates this expression. Furthermore, when DU-145 Luc cells are subcutaneously implanted and treated with Topotecan, significant tumor growth inhibition and regression are observed via caudal vein injection and bioluminescent imaging.
Cell Research
Topotecan is dissolved in sterile water to a stock concentration of 1 mg/mL, diluted to 6 μg/mL in cultured medium and then serially diluted 1:4 in opaque, white tissue culture-treated microplates to a final volume of 0.1 mL/well. MCF-7 Luc and DU-145 Luc cells are resuspended in 3×104 cells/mL in DMEM with high glucose containing 10% FBS and 0.5 mg/mL Geneticin; 100 μL of cells are added in each well. Plates are incubated for 4 days at 37 °C in 95% humidity/5% CO2. After incubation, 0.05 mL of 0.1 M HEPES buffer (pH 7.9) containing 50 μg/mL D-luciferin is added to each well. After incubation at room temperature for 10 minutes, the culture microplate is measured in a microplate luminometer and a molecular light imager. Results obtained with the microplate luminometer are calculated using no inhibition control wells without exogenous drug and maximum inhibition control wells containing ATP inhibitor. Results for the molecular light imager are similarly calculated using values obtained with a 5 minutes luminescent imager. (Only for Reference)

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Autophagy, Apoptosis, NSC-609669, NSC609699, NSC609669, NSC-609699, NSC 609669, NSC 609699, Inhibitor, Nogitecan HCl, inhibit, SKFS 104864A, SKF 104864A, Topotecan HCl, Topotecan hydrochloride, Topotecan Hydrochloride, Topotecan, Topoisomerase, Topo I (DU-145 Luc cells), Topo I (MCF-7 Luc cells)

Similar Products

  • Topotecan hydrochloride hydrate [orb1686937]

    1044663-62-8

    475.93

    C23H26ClN3O6

    50 mg, 100 mg, 25 mg
  • Topotecan hydrochloride [orb1226834]

    >98% (HPLC)

    119413-54-6

    457.92

    C23H24ClN3O5

    10 mg, 25 mg, 1 g, 5 mg, 50 mg, 500 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download
MSDS
Safety Data Sheet
Download

Request a Document

Protocol Information

Topotecan hydrochloride (orb1309516)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

10 mg
$ 160.00
50 mg
$ 300.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry